Intractable epilepsy: management and therapeutic alternatives (Q37165869)

18 August 2017

1 reference

title

Intractable epilepsy: management and therapeutic alternatives (English)

1 reference

18 August 2017

1 reference

Stephan U Schuele

1

1 reference

PubMed ID

18485315

18 August 2017

Hans O Lüders

series ordinal

2

1 reference

18 August 2017

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

7

1 reference

18 August 2017

6

1 reference

18 August 2017

514-524

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

18 August 2017

1 reference

7 January 2021

Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Risk of recurrent seizures after two unprovoked seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prognostic index for recurrence of seizures after remission of epilepsy. Medical Research Council Antiepileptic Drug Withdrawal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The natural history of epilepsy: an epidemiological view.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prognosis of chronic and newly diagnosed epilepsy: revisiting temporal aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Factors predicting prognosis of epilepsy after presentation with seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The management of refractory idiopathic epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Status epilepticus: pathophysiology and management in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Defining intractability: comparisons among published definitions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The misdiagnosis of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Guidelines for essential services, personnel, and facilities in specialized epilepsy centers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The star systems: overview and use in determining antiepileptic drug choice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The misdiagnosis of epilepsy: findings of a population study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Avoiding the costs of unrecognized psychological nonepileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Non-epileptic seizures in temporal lobectomy candidates with medically refractory seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Pseudostatus epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Outcome after diagnosis of psychogenic nonepileptic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

How many patients with psychogenic nonepileptic seizures also have epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Incidence and prognostic significance of "epileptiform" activity in the eeg of non-epileptic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Errors in EEGs and the misdiagnosis of epilepsy: importance, causes, consequences, and proposed remedies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Is the underlying cause of epilepsy a major prognostic factor for recurrence?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Changing view of prognosis of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Bringing epilepsy out of the shadows

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Management strategies for refractory localization-related seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Likelihood of seizure remission in an adult population with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Results of treatment changes in patients with apparently drug-resistant chronic epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

New antiepileptic drugs: comparison of key clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

A randomized, controlled trial of surgery for temporal-lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Practice parameter: temporal lobe and localized neocortical resections for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Practice parameter: temporal lobe and localized neocortical resections for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Lost years: delayed referral for surgically treatable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Presurgical evaluation of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

1 reference

7 January 2021

Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Predictors of outcome after temporal lobectomy for the treatment of intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Outcomes of epilepsy surgery in adults and children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Relevance of residual histologic and electrocorticographic abnormalities for surgical outcome in frontal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Factors predictive of the outcome of frontal lobe epilepsy surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prognostic factors in neocortical epilepsy surgery: multivariate analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Surgical outcome and prognostic factors of frontal lobe epilepsy surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Cerebral cavernous malformations and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Intractable epilepsy in vascular congenital hemiparesis: clinical features and surgical options.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Hemispherectomy for catastrophic epilepsy in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Developmental outcome after epilepsy surgery in infancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Surgical outcome in tuberous sclerosis complex: a multicenter survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Vagus-nerve stimulation for the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Brain stimulation for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. The Vagus Nerve Stimulation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

A risk-benefit assessment of therapies for Lennox-Gastaut syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Atypical Lennox-Gastaut syndrome successfully treated with removal of a parietal dysembryoplastic tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizures and other neurologic sequelae of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The risk of unprovoked seizures after encephalitis and meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Causes of epilepsy: contributions of the Rochester epidemiology project.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Neurophysiologic and neuroradiologic features of intractable epilepsy after traumatic brain injury in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizure localization and pathology following head injury in patients with uncontrolled epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Intractable epilepsy due to meningitis: results of surgery and pathological findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Age of meningitis or encephalitis is independently predictive of outcome from anterior temporal lobectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The use of lamotrigine in juvenile myoclonic epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Idiopathic Generalized Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The treatment of juvenile myoclonic epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Interaction of lamotrigine with sodium valproate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Valproate-ethosuximide combination therapy for refractory absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Negative effects of antiepileptic drugs on mood in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Rapid detection of major depression in epilepsy: a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Diagnosis and treatment of mood disorders in persons with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Epilepsy and risk of suicide: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Treatment of women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Epilepsy and erectile dysfunction: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Bone health in people with epilepsy: is it impaired and what are the risk factors?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

1 reference

7 January 2021

Cause-specific mortality in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Ictal asystole and SUDEP

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Video-electrographic and clinical features in patients with ictal asystole

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Review of the legal obligations of the doctor to discuss Sudden Unexplained Death in Epilepsy (SUDEP)--a cohort controlled comparative cross-matched study in an outpatient epilepsy clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

SUDEP--to discuss or not discuss: that is the question

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Population-based study of the incidence of sudden unexplained death in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizure control and mortality in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Reducing mortality: an important aim of epilepsy management

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Development of new antiepileptic drugs: challenges, incentives, and recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Antiepileptic drugs in development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The neurobiology of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The mechanisms of action of commonly used antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

An automated drug delivery system for focal epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Focal treatment for refractory epilepsy: hope for the future?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Refractory epilepsy: mechanisms and solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Electrical stimulation of the anterior nucleus of the thalamus for the treatment of intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Stimulation of the central median thalamic nucleus for epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Optimizing parameters for terminating cortical afterdischarges with pulse stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Electrophysiological effects and clinical results of direct brain stimulation for intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Effect of an external responsive neurostimulator on seizures and electrographic discharges during subdural electrode monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Implantation of a closed-loop stimulation in the management of medically refractory focal epilepsy: a technical note

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Radiosurgery for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Gamma knife surgery in mesial temporal lobe epilepsy: a prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Use of complementary and alternative medicine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

Catastrophic epilepsy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2808%2970108-X

7 January 2021

10.1016/S1474-4422(08)70108-X

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18485315